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1. Introduction 
Hepatology is an excellent example of how results deriving from basic science influence our 
everyday clinical practice. This involves diagnostic procedures as well as therapeutic 
developments. The role of diagnostic imaging in the assessment of liver disease continues to 
gain in importance. Imaging of the liver has progressed rapidly during the past decade with 
continued advancement of current ultrasound, computed tomography, and magnetic 
resonance imaging. Refinement enabling better anatomic characterization of disease and 
significant strength from the addition of new techniques and high resolution images were 
seen. Improvements in ultrasound (US) scanners over the past few decades have been 
remarkable: advances such as color Doppler and harmonic imaging have increased image 
quality and accuracy. Ultrasound is usually the first imaging modality in the evaluation of 
liver disease because it is easy to perform, widely available, relatively inexpensive and is 
cost effective. US can detect morphological changes in the liver and characterize focal 
lesions (cystic or solid) with high accuracy. Color Doppler sonography is a well established 
method for assessment of the hepatic vasculature, offering hemodynamic and anatomical 
information. 
2. Hepatic ultrasound in rodents 
An important challenge in pre-clinical in vivo studies is to follow up the evolution of the 
disease induced in animal models without sacrifice them. In this context, noninvasive 
methods available for the diagnosis and prognosis of liver diseases bring a significant 
contribution for the progress of this field of study. Prior animal research may support the 
step forward to human clinical trials. 
Rodents represent an important animal group used in experimental model of liver diseases. 
Steatosis, cirrhosis and some hepatic focal lesions can be induced in mice and rats by 
administration of toxins, among which carbon tetrachloride (CCL4), ally alcohol, retrorsine 
and 2-acetylaminofluorene (2-AAF), by surgical insult such as bile duct ligation or hepatic 
resection, and virus infection. The induced hepatopathies may present change in liver size, 
shape, position, or opacity and these parameters can be evaluated by ultrasound imaging. 
US imaging is an ideal complementary diagnostic tool to evaluate the liver. Hepatic 
ultrasound can noninvasively examine the internal architecture of the liver parenchyma, 
biliary system, portal and hepatic vascular supply. Also, ultrasonography allows assessment 
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of changes in liver echogenicity, which correlates with disease (Lessa et al., 2010); identifies 
focal verses diffuse disease processes (Lima et al., 2008); detects vascular and biliary 
abnormalities (Partington & Biller, 1995). Additionally, besides being a noninvasive method, 
US is innocuous, reliable, rapid, reproducible and inexpensive, with high accuracy in 
evaluating liver disease. 
2.1 Scanning techniques for hepatic ultrasound in rodents 
Tranquilization is always required. In our experience, animals are successfully anesthetized 
using Ketamine (0.5mL/kg) and Xilazin (1mL/kg) intraperitoneally or by inhalation of 
Isoflurane, USP. If possible, the rodent should be fasting for 12 hours. This preparation may 
prevent vomiting and aspiration during anesthesia and helps reducing the sonographic 
barriers of excessive gas in the stomach and intestine. 
The ventral abdomen must be shaved or have the hair removed with a commercially 
available hair remover creme to reduce imaging artifacts in the ultrasonographic 
examination. A sound-conducting gel is applied and the US examination can be performed 
in rats using a multifrequencial linear transducer (7.5 to 12MHz) attached to a conventional 
ultrasound machine or can be performed in mice and in rats using mechanical sector high 
resolution transducers (30 MHz and 40 MHz) in a dedicated ultrasound equipment for small 
animals (Vevo 770 - Visualsonics – Canada). 
The animals are positioned in dorsal recumbence on a rectangular table for liver, hepatic 
artery and portal vein scanning. The liver is assessed by placing the transducer just distal to 
the last right costal cartilages and angling its beam cranially, obtaining multiple transversal 
and longitudinal scans (Fig. 1A-D). The hepatic artery and portal vein are scanned in the 
longitudinal views.  
 
 
Fig. 1. Liver scanning: [1.A] Longitudinal scans are made by angling the transducer beam 
from right to left; [1.B] Transversal scans are made by angling the transducer beam from 
cranial to caudal; [1.C] High resolution mechanical sector transducer; [1.D] Dedicated 
ultrasound table with inhalatory anesthesia system. 
C D 
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2.2 The normal hepatic ultrasound 
In order to standardize normal US parameters, our research group has examined 276 
healthy Wistar rats. Such as described in small animals, the liver is bounded cranially by the 
concave highly echogenic curvilinear structure of the diaphragm-lung interface. It is 
bordered caudally by the fluid and gas reverberations in the fundus and body of the 
stomach to the left, and the pylorus and right kidney to the right. The anatomy divides the 
rat liver in four lobes: the right lateral lobe, middle, left lateral and caudate lobes, which in 
turn have independent portal and arterial vascularization and a separate biliar drainage. 
The right lateral lobe is subdivided into two segments, anterior and posterior, the last one 
adjacent to the right kidney and placed behind the inferior vena cava. The left lateral lobe is 
located on the left, in front of the stomach. In the midline, the caudate lobe is located 
dorsally and the median lobe lies ventrally. 
The liver has homogeneous parenchyma with medium level echogenicity and straight 
hepatic surface as normal characteristics (Fig. 2A) (Dias et al., 2008; Lessa et al., 2010; 
Manheimer et al., 2009). In the 276 rats we examined, the transverse diameter of the liver 
measures from 3.5 to 3.8 cm and the portal vein caliber between 1.5 mm and 1.6 mm. The 
hepatic parenchyma is less echogenic than the right renal cortex in the great majority of 
rodents. Similar echogenicity in both organ parenchymas is observed in less than 5% of 
them (Lessa et al., 2008). The ultrasonographer should attempt to obtain images of the liver 
adjacent to the right kidney (longitudinal scan) (Fig. 2B). These images have to be made with 
proper control settings to prevent an incorrect diagnosis of diffuse hepatic disease. The 
hepatic parenchyma contains variably sized circular and tubular anechoic structures that 
represent the hepatic and portal veins (Partington & Biller, 1995).  
 
 
Fig. 2. Liver sonograms of a healthy rat: [2.A] Transversal sonogram shows homogeneous 
liver parenchyma, with medium level echogenicity and a regular hepatic surface 
(arrowheads); [2.B] Longitudinal sonogram presents right renal cortex more echogenic than 
liver parenchyma.  
The caudal vena cava and the portal vein are parallel and run longitudinally.  The portal 
vein caliber is measured in the mid-point of the main portal vein (Fig. 3A). Intrahepatic bile 
ducts are not identified routinely with ultrasound. Rats do not have gallbladder but mice do 
have it. The spleen has a homogeneous parenchyma (Fig.3B).  
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Fig. 3. [3.A] Longitudinal sonogram: portal vein (PV) (arrows) and the caudal vena cava 
(CVC) (arrowheads) in a healthy rat; [3B] Spleen sonogram: measurement of its area.   
In high resolution ultrasound equipment specially designed to evaluate small animals the 
liver parenchyma and the relationship between liver/kidney echogenicity in rodents can be 
accurately examined. The portal vein caliber of the mice measures around 1.0 mm and the 
hepatic artery around 0.2 mm. This equipment allows to use the Doppler method to 
evaluate vascular resistance. The hepatic artery has a normal low resistance flow with the 
resistive index (RI) measuring around 0.50 (Fig. 4A-C). Resistive index (RI) is calculated 
using the peak systolic velocity (S) and end diastolic velocity (D) measurements as follows:  
S-D
RI=
S
 
 
    
Fig. 4. [4.A] Longitudinal scan: normal liver parenchyma less echogenic than the renal 
cortex. [4B] Longitudinal scan:  normal portal vein (PV) - caliber: 0.85 mm. [4C] Doppler 
spectrum: normal low resistance flow of the hepatic artery with high diastolic flow. 
2.3 Difuse hepatic disease 
Difuse hepatic disease may cause a change in the echogenicity of hepatic parenchyma (Dias 
et al., 2008; Lessa et al., 2010). Increased echogenicity is identified as hepatic echogenicity 
equal or greater than the renal cortex and similar to the spleen (Lessa et al., 2010; Lima et al., 
2008; Partington & Biller, 1995). Diseases that may cause an increase in hepatic echogenicity 
include cirrhosis, hepatic steatosis, steroid hepatopathy, lymphosarcoma, and long-term 
cholangiohepatitis (Partington & Biller, 1995).  
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In 2005, Lee et al. demonstrated that B-mode mean grey level has a close correlation with 
fatty change and it is useful for the diagnosis of liver fibrosis (Lee et al., 2005). In 2008, it was 
described that US revealed steatosis based on liver echogenicity relative to the kidney and 
could detect focal lesions up to 0.5 mm in a rat model of NASH (non-alcoholic 
steatohepatitis) with cirrhosis (Lima et al., 2008).  
In 2010, our group determined the reliability of US findings in the assessment of fatty liver 
disease and cirrhosis in rats in comparison to histological results by following up a rat 
model of hepatic disease induced by dual exposure to CCl4 and ethanol (Lessa et al., 2010). 
In brief, ultrasound analysis was performed after 4, 8 and 15 weeks of liver injury induction, 
following the scanning techniques for hepatic ultrasound in rodents described above. 
Ultrasonographic findings were analyzed based on our previous observations and on 
criteria for US diagnosis in humans according to the following classification: 
A. Liver echogenicity (Fig. 5) - four patterns: (0) homogeneous liver parenchyma with 
medium level echogenicity and a regular hepatic surface; (1) diffusely increased 
parenchymal echogenicity, reduced visualization of the diaphragm and small peripheral 
vessels  with no change on liver surface; (2) discrete coarse and heterogeneous parenchymal 
echogenicity, dotted or slightly irregular liver surface; (3) extensive coarse and 
heterogeneous parenchymal echogenicity, irregular or nodular hepatic surface with 
underlying regenerative nodules; 
 
 
Fig. 5. Liver echogenicity patterns:  
[5A] Pattern 0  
[5B] Pattern 1 
[5C] Pattern 2 
[5D] Pattern 3 
B. Inversion of the echographic relationship between the liver and the renal cortex (Fig. 6). 
This finding was considered to be positive if the echogenicity of the liver parenchyma was 
greater or equal to the right renal cortex, instead of lesser than it; 
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Fig. 6. Relationship between liver and right kidney echogenicities: Longitudinal scan       
[6A] Liver is less echogenic than right renal cortex; [6B] Hepatic echogenicity is equal to the 
right renal cortex in a cirrhotic liver; [6C] Hepatic parenchyma is more echogenic than right 
renal cortex in a steatotic liver. 
C. Increased portal vein caliber (PVC). PVC was considered to be abnormal if equal or 
greater than 2.1 mm; 
D. Presence of ascites; 
E. Spleen area; 
F. Doppler waveforms of the hepatic artery shows an increase in the resistive index due to 
the difficult inflow related to the presence of diffuse liver disease. 
The liver parenchymal echogenicity changes correlates to the time of injury induction. The 
first pattern of liver echogenicity (pattern 0) is identified in normal rats. The pattern 1 
correlates to fatty liver without/with minimal fibrosis. The pattern 2 corresponds to 
steatosis associated to different degrees of fibrosis and pattern 3 correlates to cirrhosis. 
Cirrhosis may present nodules from macronodular regeneration (Lessa et al., 2010; 
Partington & Biller, 1995). As these nodules are most commonly isoechoic, their 
identification by ultrasound is difficult (Biller et al., 1992).  
The hepatic echogenicity increases due to the presence of fatty infiltration and/or fibrosis, 
changing the relation between liver and right renal cortex (Biller et al., 1992). In our 
experience, this inversion had high sensitivity (90%), specificity (100%), positive and 
negative predictive values (100% and 76.9% respectively), and accuracy (92.5 %) for the 
detection of hepatic steatosis (Lessa et al., 2010), which is compatible with the findings 
described in the literature (Biller et al., 1992; Palmentiere et al., 2006).  
Rats with mild hepatic steatosis can appear to be normal in US examination (Lessa et al., 
2010). The US has been reported to have sensitivity of 90-91% for the detection of moderate 
to marked steatosis, but its sensitivity decreases to 30–64% when fatty liver is mild (Biller et 
al., 1992; Palmentiere et al., 2006). In addition, it is important to exclude kidney diseases 
when using this approach (Biller et al., 1992). 
The evaluation of portal hypertension is important to access the severity of the disease. One 
of its most important signs is the widening of the portal vein (Fig.7). The PVC presented 
statistically significant differences (p<0.001) between cirrhotic and non-cirrhotic rats. The 
increase in its caliber, which was greater or equal to 2.1mm, can be considered a relevant 
ultrasound parameter, with sensitivity of 100% and specificity of 90.5 % (Lessa et al., 2010). 
Additionally, a 50% increase in PVC after cirrhosis induction can be another good parameter 
for advanced hepatic fibrotic change (Mannheimer et al., 2009). 
Among the imaging diagnostic methods, the ultrasound is considered ideal for the study of 
ascites, which can be observed even when mild. Considering diffuse hepatic disease, the 
presence of ascites invariably corresponds to cirrhosis (Fig. 8)  
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Fig. 7. Portal vein caliber (PVC): Longitudinal scans - [7A] Straight and thin portal vein 
(caliber=1.4 mm) in a healthy rat (arrows); [7B] Tortuous and dilated portal vein (caliber=2.2 
mm) in a cirrhotic rat (arrows). 
 
 
Fig. 8. [8A] Transversal liver sonogram shows a small cirrhotic liver with marked ascites; 
[8B] Longitudinal sonogram presents a great amount of ascites surrounding the spleen. 
2.4 Focal liver lesions 
Focal hepatic lesions are more easily detected by ultrasound when these lesions have  
a different echogenicity than the surrounding normal liver. Focal hepatic diseases  
include cysts, hematomas, abscess, granulomas, regenerative nodules, primary and 
metastatic neoplasms (Partington & Biller, 1995). US usually detects and characterize 
these lesions. 
Regenerative hepatic nodules are benign reorganized masses of hepatic tissue that contain 
lipid, blood-filled sinusoids, lymphocytes and areas of atrophied or necrotic hepatocytes. 
These nodules are most commonly isoechoic and can be multiple and variably sized  
(Fig. 9). 
Primary hepatic neoplasia may appear as solitary or multiple focal lesions that can be hypo, 
iso or hyperechoic in relation to normal liver.  Also it can appear as a very large, moderately 
circumscribed or infiltrating mass. The US appearance of liver neoplasia is not specific for 
the histopathological cell type (Partington & Biller, 1995). 
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Fig. 9. Transversal sonogram shows a cirrhotic liver with an isoechoic regenerative nodule 
(arrow).  
3.  Human liver ultrasound imaging 
The liver is the largest abdominal organ weighting 1.5 kg and lying in the right side of the 
upper abdomen under the right hemidiaphragm and extending across the midline to the left 
hypochondrium. The parenchymal echoes are a mid-grey and consist of a uniform, sponge-
like pattern interrupted by the vessels. In transverse sections the wedge shape of the liver is 
seen, tapering to the left (Fig.10A).  The caudate lobe is seen as an extension of the right lobe 
in transverse sections and as an almond-shaped structure posterior to the left lobe in 
longitudinal views (Fig.10B). In the longitudinal sections the liver has a triangular shape, the 
right lobe larger than the left (Fig. 10C).  
 
 
Fig. 10. [A] Transversal section of normal liver with the hepatic veins draining into the 
inferior vena cava. [B] Longitudinal scan of the left and caudate lobe being separated by the 
fissure of the ligamentum venosum (arrowhead); [C] Longitudinal scan of the liver: normal 
left lobe and right lobe. 
3.1 Technique 
The liver is best imaged with the patient supine or in a right anterior oblique position. 
Intercostal imaging is always required, in which case the transducer is placed parallel to the 
adjacent ribs to avoid acoustic shadowing. Multiplanar imaging of the liver is obtained.  
Sagittal, transverse, coronal and subcostal oblique views are required.  A 5-2 MHz curved 
array transducer with appropriate gain and depth settings permits adequate visualization of 
the entire liver. A wide field of view in the near field is essential for good liver imaging. The 
A B
Transversal Longitudinal
Caudate lobe
Left liver
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liver should be imaged in real-time in the sagittal and transverse or oblique planes. The left 
lobe is usually best imaged with the patient supine and the transducer placed in an anterior 
subxiphoid position. Real-time imaging during suspended deep inspiration allows the most 
superior aspects of the left lobe to be visualized. The right lobe usually requires an 
intercostal or subcostal oblique approach with the patient supine and in the left-side-down 
decubitus position. Certain regions are more difficult to image such as the high dome and 
the lateral aspect of the right lobe of the liver, usually best imaged from subcostal oblique 
and intercostal planes in suspended inspiration. The patient should be fasting for at least 6 
hours prior to the exam to limit bowel gas and so that the gallbladder is not contracted. 
3.2 Focal liver lesions 
Liver masses are increasingly being identified due to the widespread use of imaging   
modalities. The majority of these lesions are detected incidentally in asymptomatic patients.  
Characterization of a liver mass on sonography is based on the appearance of the mass on 
gray scale imaging as well as on vascular information that may be obtained on Doppler 
examination.  
3.2.1 Hepatic cysts 
Simple cysts are usually described as congenital lesions, but are probably better considered 
developmental, since their frequency increases with age. Simple hepatic cysts are usually 
solitary, have a thin epithelial lining, and contain watery fluid. Their size varies from less 
than 1 cm to more than 20 cm in diameter. Simple cysts are found 4 times more frequently in 
females than males. Symptoms are rare, but may occur from mass effect, rupture, 
hemorrhage or infection. The classic sonographic findings are well known: a well defined, 
anechoic lesion with a well-demarcated, thin wall and good distal sonic enhancement (Fig. 
11A). Thin septations are frequent, and should not suggest a different diagnosis. 
Occasionally there may occur cyst hemorrhage or infection when it will contain internal 
echoes and septations, a thickened wall and may appear solid (Fig. 11B). If thick septae or 
nodules are seen, differential diagnosis of biliary cystadenomas and cystic metastases must 
be considered. Acquired cysts are usually secondary to trauma, inflammation or parasitic 
infection and are indistinguishable from primary cysts. Cyst ablation with alcohol or 
surgical excision can be performed if indicated. 
 
 
Fig. 11. [A] Hepatic cyst: a well defined, anechoic lesion with a thin wall and good distal 
enhancement; [B] Hemorrhagic cyst - a well defined cystic lesion with internal amorphous 
echoes and septation; [C] Polycystic liver disease: multiple anechoic cysts of varying sizes, 
thin walls and posterior distal enhancement. Note that some cysts contain internal echoes 
with fluid/fluid level due to internal hemorrhage. 
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Polycystic renal disease is a relatively common congenital condition and has an autosomal 
dominant mode of inheritance. Liver cysts are associated with this condition in 
approximately 57% to 74% (Levine et al., 1985). The most common presentation is 
hepatomegaly.  The ultrasound appearance of multiple cysts of varying sizes, thin walls and 
posterior acoustic accentuation is characteristic (Fig. 11C). Hemorrhage or infection in the 
cysts may produce internal echoes. Acoustic accentuation beyond each cyst may produce 
the impression of an abnormal liver parenchymal texture. There may be cysts in other 
organs like pancreas, spleen, ovaries and lungs. Usually they do not require any treatment 
and complications are rare including hemorrhage, rupture or infection. 
3.2.2 Biliary hamartomas (von Meyenburg Complexes) 
Bile duct hamartomas are small focal developmental lesions composed of groups of dilated 
intrahepatic bile ducts with a collagenous stroma. They are benign liver malformations that 
are detected incidentally in 0.6 to 5.6% of reported autopsy series (Redston & Wanless, 
1996). Commonly they are documented on sonograms as bright echogenic foci with distal 
ringdown or comet tail artifacts, diffusely distributed until the periphery of the liver (Fig. 
12A-B) that could be related to the presence of tiny cysts beyond the resolution of the 
ultrasound equipment or to the cholesterol crystals within the dilated tubules. They may 
also appear as well-defined small hypoechoic solid nodules (Fig. 12C-D). 
 
A B C D
Transversal TransversalLongitudinal
 
Fig. 12. Biliary hamartomas: [A-B] multiple bright echogenic foci some of them with distal 
ringdown or comet tail artifacts, diffusely distributed until the periphery of the liver; [C-D] 
Small hypoechoic nodule that on MRI was confirmed to be von Meyenburg complex. 
3.2.3 Hydatid disease 
The liver is the most frequently involved organ in hydatid disease but other sites may be 
involved, such as the lungs, the bones, the brain and the peritoneal cavity.  In the liver the 
right lobe is more frequently involved where they form slow-growing cysts. Lewall & 
McCorkell (1985) proposed four groups of sonographic features of hepatic hydatid disease:  
solitary cysts containing sand; cysts with detached endocyst secondary to rupture; cysts 
with daughter cysts; and densely calcified masses. The distinction between simple and 
hydatid cysts may be one of the following features: wall calcification, debris consisting  
of sand and the two layers of the wall resulted from detachment and collapse of the inner 
germinal layer from the exocyst. The development of daughter cysts produces a 
characteristic appearance.    
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3.2.4 Hepatic abscess 
Liver abscesses are frequently related to direct extension from the biliary tract infection in 
patients with suppurative cholangitis and cholecystitis or to complications of an intra-
abdominal infection with direct portal venous system spread to the liver, such as 
diverticulitis or appendicitis. They may also be present in the liver as a result of blunt or 
penetrating trauma or through the hepatic artery in patients with osteomyelitis and 
subacute bacterial endocarditis. No cause can be found in approximately 50% of the cases of 
hepatic abscesses (Wilson & Withers, 2005). 
Sonographically, pyogenic liver abscess has a variable appearance. Typically, pyogenic 
abscesses are poorly defined, irregularly marginated, and primarily hypoechoic. Irregular 
areas of increased echogenicity are frequent (Fig.13A-B). Bright punctate echoes often 
represent gas within the abscess. On occasion, a diffusely hyperechoic appearance may be 
noted, related to large amounts of gas from gas-forming organisms (Fig. 13C-D). Fluid-fluid 
interfaces, internal septations and debris can be observed. The abscess wall can vary from 
well-defined to irregular and thick. Diffuse microabscesses may occasionally cause a 
confusing sonographic pattern of increased irregular hepatic echogenicity. The differential 
diagnosis of pyogenic liver abscess includes complicated hepatic cysts with hemorrhage, 
hematoma, amebic infection and necrotic neoplasm.  
 
A B C D
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Fig. 13. [A-B] Hepatic abscess - Thick wall fluid collection with hyperechoic heterogeneous 
internal echoes; [C-D] Gas forming abscess - diffusely irregular hyperechoic lesion with 
posterior accoustic attenuation. 
Entamoeba histolytica primarily infects the colon. Transmission is by the fecal-oral route. 
Amebic liver abscess is the most common non-enteric complication of amebiasis. The most 
common presenting symptom is pain. An amebic abscess may be indistinguishable from a 
pyogenic abscess. Sonographic features include lack of a significant wall echo, symmetric 
oval or round configuration, hypoechogenicity compared to normal liver with a 
homogeneous pattern of internal echoes, increased sound transmission and subcapsular 
location (Fig. 14). Ralls et al. (1987a) in a review of 112 amebic lesions described two 
sonographic patterns that were more prevalent in amebic abscesses: round or oval shapes in 
82% versus 60% of pyogenic abscess and hypoechoic appearance with fine internal echoes at 
high gain in 58% versus 36% of pyogenic abscesses. The majority of hepatic amebic 
abscesses disappear with amebicidal drugs (Ralls et al., 1987b). 
3.2.5 Cavernous hemangioma 
Cavernous hemangiomas are the most frequently encountered benign tumor of the liver and 
are seen in 1 to 4% of the population as an incidental finding. These lesions are most  
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Fig. 14. Amebic abscess: lack of significant wall echo, round hypoechoic liver lesion with 
increased sound transmission and subcapsular location. 
commonly seen in women with a female/male ratio of 5:1 (Snover, 2009). Hemangiomas are 
composed of dilated endothelial-lined vascular channels, infiltrated by varying degrees of 
fibrous stroma. 
The typical hemangioma is a uniformly well circumscribed hyperechoic mass less than 3 cm 
in diameter. These lesions are often small and can be multiple (Fig. 15A-B). The increased 
echogenicity has been related to the numerous interfaces between the walls of the cavernous 
sinuses and the blood within them. In the setting of hepatic steatosis or cirrhosis, however, 
they may appear hypoechoic. Although this lesion is hyperechoic, in many cases 
hemangiomas will exhibit posterior acoustic enhancement because the dilated, fluid-filled 
sacs of blood do not attenuate sound. An atypical but not uncommon sonographic 
appearance of the hemangioma is a lesion with an echogenic rim and an internal hypoechoic 
pattern (Wilson & Withers, 2005) (Fig.15C-D). Larger lesions tend to be heterogeneous with 
central hypoechoic foci corresponding to fibrous collagen scars, large vascular spaces, or 
both. Calcification is rare. Hemangiomas only rarely demonstrate internal flow on Doppler 
studies, due to the multidirectionality and slow velocity of flow. There are potentially 
significant lesions that may mimic the morphology of a hemangioma on ultrasound and 
produce a single mass or multiple masses of uniform increased echogenicity such as 
metastases from a colon primary tumor; small hepatocellular carcinomas (HCC) may show 
this morphology. Caturelli et al. (2001) in a prospective evaluation of 1982 patients with 
newly diagnosed cirrhosis found that 50% of echogenic liver lesions suggestive of  
 
A B C D
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Fig. 15. Hemangioma: [A-B] Typical hemangioma: hyperechoic round lesion at the posterior 
segment of the right lobe of the liver with posterior acoustic enhancement; [C-D] Multiple 
hemangiomas: Multiple echogenic lesions with central hypoechoic areas. 
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hemangiomas had the diagnosis of HCC. These results emphasize the importance to prove 
the diagnosis of all masses with this morphology in high-risk patients. 
3.2.6 Focal nodular hyperplasia 
Focal nodular hyperplasia (FNH) is the second most commonly encountered benign liver 
lesion and is seen most often as an incidental observation in a young adult female. FNH is 
not an actual neoplastic tumor but represents instead a hyperplastic response to an 
underlying vascular malformation in the liver. Histologically, it is made up of normal liver 
components, including hepatocytes and Kupffer cells. FNH is a hypervascular lesion, often 
showing a central stellate vascularity and a large and tortuous feeding artery. On 
sonography, FNH is often a subtle liver mass that is difficult to differentiate in echogenicity 
from the adjacent liver parenchyma (Fig.16A-B). The lesions may be slightly hypoechoic, 
isoechoic, or slightly hyperechoic than the surrounding liver. Use of color and power 
Doppler US may add information concerning the vascularity of the suspected FNH.  
In addition, use of US contrast media to characterize FNH has been reported. These lesions 
usually produce a contour abnormality to the surface of the liver or may displace the normal 
blood vessels within the parenchyma. The central scar may be seen on gray-scale sonograms 
as a hypoechoic linear or stellate areas within the central portion of the mass. Well-
developed peripheral and central blood vessels are seen to course within the central scar 
with either a linear or stellate configuration (Fig.16C-D).  Spectral interrogation usually 
shows predominantly arterial signals centrally. 
 
A B C D
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Fig. 16. Focal Nodular Hyperplasia. [A-B] Isoechoic large lesion in the right lobe deforming 
the contour of the liver with a subtle hypoechoic central area; [C-D] Color Doppler showing 
stellate pattern blood vessels within the central scar. 
3.2.7 Hepatic adenoma 
Hepatic adenomas (HA) are less common than FNH, benign neoplasms, usually solitary and 
well encapsulated, ranging in size from 8 to 15 cm, which have a small risk for malignant 
transformation into hepatocellular carcinoma, as well as a propensity for hemorrhage and 
rupture. The majority of these lesions occur in young women taking oral contraceptives. The 
risk of developing HAs is related to both the duration of use and dose of hormones. These 
lesions regress when oral contraceptives are discontinued (Fig.17A-F). Other populations 
noted to have an increased incidence of HAs include individuals with type I glycogen 
storage disease. In these patients, hepatic adenomas tend to be multiple. The sonographic 
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appearance is nonspecific. Although in 70% to 80% of cases, HAs present as a solitary and 
large hyperechoic lesion with central anechoic areas, corresponding to zones of internal 
hemorrhage, they can be isoechoic or complex masses. It is difficult to distinguish hepatic 
adenoma from FNH. Color Doppler evaluation can be helpful, demonstrating peripheral 
and intratumoral vessels showing increased venous structures within the center of the mass 
and a paucity of arterial vessels (Fig.17G-H). These lesions are substantially less vascular 
than most FNH (Wilson & Withers, 2005). 
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Fig. 17. Hepatic Adenoma: [A-F] Isoechoic lesion in the left lobe of the liver that diminished 
in size as oral contraceptives were discontinued (A-B: 1st exam, C-D: 2nd exam, E-F: 3rd exam- 
every two months); [G-H] Color Doppler showing predominantly peripheral vessels. 
3.2.8 Hepatocellular carcinoma   
Hepatocellular carcinoma (HCC) is the commonest primary liver cancer, comprising 80% of 
primary liver malignancies in the United States. The majority of HCC patients (95% in the 
western, 60% in Asian countries) will develop the disease on the ground of preexisting liver 
cirrhosis. Alcoholic cirrhosis-related HCC has a lower frequency (10% of autopsied patients) 
than HBV or HCV (Parkin et al., 2005). Although α-fetoprotein (AFP) is a known and 
specific tumor maker for HCC, it is not suitable for the screening and surveillance of HCC 
because of its poor predictive value and low sensitivity. The use of imaging modalities is 
essential for the screening, diagnosis and treatment of HCC. US plays a major role among 
them, because it provides real-time and noninvasive observation by a simple and easy 
technique. The development of digital technology has led to the detection of blood flow by 
color Doppler US, and the sensitivity for detecting tumor vascularity has shown remarkable 
improvement with the introduction of microbubble contrast agents.  Screening generally 
consists of serologic testing for alpha-fetoprotein and/or hepatitis B and C, often coupled 
with sonography of the liver. Some studies showed that surveillance based on US and AFP 
every 6-12 months improved the survival of patients (Bolondi et al., 2001; Sangiovanni et al., 
2004). Pathologically HCC occurs in three forms: 1. Solitary tumor; 2. Multiples nodules; 3. 
Diffuse infiltration. Sonographic findings in HCC are variable, and may cause difficulty in 
distinguishing advanced HCC from metastatic disease. This is less of a problem in screening 
programs, where HCCs less than 5 cm are often detected. In these small lesions, sonographic 
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findings are not as diverse. About 75% of small HCCs (<5 cm) are hypoechoic (Fig.18A-B). 
As HCCs enlarge, they tend to develop hypoechoic peripheral rims. With further 
progression, lesions become more numerous and heterogeneous. Some hepatocellular 
carcinomas, even small lesions, undergo fatty metamorphosis, causing increased 
echogenicity and potential confusion with hemangioma. Hepatocellular carcinomas arising 
in normal livers are uncommon. Fibrolamellar HCC, which accounts for 2% of 
hepatocellular carcinoma, but 25% to 50% of HCC in young adults, often arises as a single 
well-circumscribed lesion with lobulated margins in an otherwise normal liver. Other 
features may include a “central scar” and a high prevalence of calcification. Vascular 
invasion is common and should suggest the diagnosis of HCC. HCC invades portal veins 
more frequently than hepatic veins. Intravascular tumor is usually reflective and expands 
the vessel, but positive differentiation from blood thrombus depends on detecting arterial 
Doppler signals from within the thrombus (Fig. 18C-F); only venous signals are found in 
blood thrombus as it is recanalized. HCC has a characteristic hypervascular appearance 
with centripetal blood flow, and a basket pattern is one of the typical findings of HCC by 
color Doppler imaging (Tanaka et al., 1990). Using microbubble contrast agents HCC shows 
as a highly vascular lesion in the overwhelming majority of patients studied. 
 
Transversal
Transversal Transversal
Transversal
Longitudinal
Portal vein
A B C D
E F
 
Fig. 18. Hepatocellular Carcinoma: [A-B] Lobulated hypoechoic lesion in the periphery of 
the right lobe; [C-F] Hipoechoic lesion in segment IV with portal tumoral thrombus. Note on 
color Doppler that the lesion has intra and peripheral vascularity (E) and that there is 
arterial flow inside the portal vein (F). 
3.2.9 Cholangiocarcinoma 
Cholangiocarcinoma arises from the bile ducts, and account for about 10% of all primary 
liver cancers. Cholangiocarcinoma is associated with hemochromatosis, ulcerative colitis, 
Caroli disease and choledochal cyst. Cholangiocarcinoma has two forms, peripheral 
cholangiocarcinoma (PCC) and hilar cholangiocarcinoma, also known as Klatskin tumor, 
when it involves the confluence of the left and right hepatic ducts at the porta hepatis. In the 
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United States, PCC is 3 times more common than hilar cholangiocarcinoma. The prevalence 
is equal in Japan. PCC is usually a large tumor, while hilar cholangiocarcinoma presents 
earlier with ductal obstruction and jaundice, and is usually not associated with a large mass. 
Hemochromatosis is associated with both PCC (9% of patients) and HCC (18% of patients). 
The sonographic findings in PCC are variable. In general, cholangiocarcinomas are hard  
to visualize with all modalities. Some investigators report predominance of hypoechoic 
lesions, and others predominantly hyperechoic lesions. Our experience suggests that slightly 
hypoechoic lesions are more frequent. Portal venous invasion is frequent. Sonography  
is generally superior to multiphase helical CT in demonstrating masses associated with hilar 
cholangiocarcinomas. Dilatation of the biliary tree can be followed down to the point  
of obstruction, where it may be possible to detect a solid, poorly reflective mass which,  
if large enough, can be seen to have a heterogeneous internal echo pattern and ill-defined 
margins (Fig.19). 
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Fig. 19. Cholangiocarcinoma: large hilar hypoechoic mass with right and left intrahepatic 
bile ducts dilatation. 
3.2.10 Metastatic disease 
In the United States, metastatic disease is by far the most common significant focal liver lesion. 
Metastases are 18 to 20 times more common than hepatocellular carcinoma (HCC) and 
produce symptoms 10 times more frequently. In one large autopsy series (Edmonson, 1987), 
38% of all patients with carcinoma had hepatic metastases. The most common carcinomas 
metastasizing to the liver include, in order of decreasing frequency: gallbladder, colon, 
stomach, pancreas, breast and lung. Metastatic disease is multifocal in approximately 90% of 
patients. Most metastases to the liver are blood-borne via the hepatic artery or portal vein. The 
portal vein provides direct access to the liver for tumor cells originating from the 
gastrointestinal tract and probably accounts for the high frequency of liver metastases from 
organs that drain into the portal circulation. Virtually any sonographic appearance may occur 
in liver metastasis. The following sonographic appearances of metastatic liver disease have 
been described: echogenic, hypoechoic, target, calcified, cystic and diffuse. Hypoechoic halos 
are common. The presence of a hypoechoic halo surrounding a liver mass has been regarded 
as an ominous sign with a high association with malignancy, particularly metastatic disease. 
Wernecke et al. (1992) described the importance of the hypoechoic halo in the differentiation of 
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malignant from benign focal hepatic lesions. Its identification has a positive and negative 
predictive value of 86% and 88%, respectively. Echogenic metastases tend to arise from a 
gastrointestinal origin or from HCC (Fig.20A). While it must be emphasized that sonographic 
appearance is a poor predictor of the primary tumor, certain patterns may be suggestive. For 
example, large to moderate-sized hyperechoic metastases, especially those with 
microcalcifications, should suggest the possibility of a colonic primary. A target or bull’s eye 
appearance with varying rings of hypo- and hyperechogenicity are common (Fig. 20B). Ill-
defined infiltrative disease with focal nodularity is another fairly frequent pattern. Metastasis 
and HCC may be impossible to distinguish sonographically, although the presence of 
underlying liver disease favors HCC. Invasion of the portal or hepatic veins suggests 
hepatocellular carcinoma, rather than metastasis. Most liver metastases that are hypoechoic are 
hypovascular. Colon, lung, breast, and gastric cancers are the most common causes of 
hypovascular liver metastases (Fig.20C). The most common causes of hypervascular hepatic 
metastases include neuroendocrine tumors (eg, carcinoid, pheochromocytoma, and islet cell 
tumors), renal cell carcinoma, melanoma, choriocarcinoma, and thyroid carcinoma. Breast 
carcinoma and, rarely, pancreatic adenocarcinoma can also cause hypervascular metastases. 
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Fig. 20. Metastases: [A] Multiple echogenic nodular lesions due to HCC metastases (gray 
arrowheads); [B] Bull’s eye appearance and another echogenic lesion secondary to colon 
carcinoma (arrow); [C] Multiple hypoechoic nodular lesions; metastases from 
cholangiocarcinoma (white arrowheads). 
3.3 Diffuse liver disease 
Recent innovations in imaging technology and contrast media development have 
augmented the role of radiology in the detection, characterization, and follow up of diffuse 
liver diseases. Although biopsy still remains the gold standard for establishing the diagnosis 
of diffuse liver disease, imaging is used to narrow the differential diagnosis, to follow up 
patients in which the diagnosis has been made, to detect complications, and to monitor 
response to therapy. 
3.3.1 Fatty liver 
Hepatic steatosis or fatty changes is an acquired, reversible disorder of metabolism and can 
result from a variety of pathologic processes including increased production or mobilization of 
fatty acids (e.g., hyperalimentation, starvation, obesity, steroid use, diabetes mellitus, and 
gastrointestinal bypass surgery) or decreased hepatic clearance of fatty acids from 
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hepatocellular injury (e.g., alcoholic liver disease, hepatitis, drug-induced liver disease, and 
liver transplantation). The distribution of steatosis can be quite variable, ranging from focal to 
regional to diffuse. Histopathologically, the hallmark of all forms of fatty liver is the 
accumulation of fat globules within the hepatocytes. If accompanied by inflammation but not 
associated with alcohol abuse, the condition is called nonalcoholic steatohepatitis. Probably the 
most common cause of a fatty liver is obesity. Correction of the primary abnormality will 
usually reverse the process, although it is now recognized that fatty infiltration of the liver is 
the precursor for significant chronic disease in a percentage of patients. 
Diffuse steatosis is common. It has been detected in up to 7% of abdominal CT 
examinations, and a relatively recent autopsy series found significant steatotic changes in 
7% of nonobese patients and 29% of obese patients (El-Hassan et al., 1992; Wanless & Lentz, 
1990).  Generally, patients with steatosis are asymptomatic, although some individuals may 
present with abnormal liver function tests or right upper quadrant pain, the latter probably 
due to distention of Glisson’s liver capsule from hepatomegaly. In patients with pure 
hepatic steatosis without coexistent hepatocytic injury, weight reduction or stopping the 
underlying etiologic factor usually reduces the amount of fatty change. 
Sonography of fatty infiltration may be varied. Mild steatosis is detected when there is 
minimal diffuse increase in hepatic echogenicity with normal visualization of diaphragm 
and intrahepatic vessels (Fig.21A). Moderate steatosis is seen as moderate increase in 
hepatic echogenicity with slightly impaired visualization of intrahepatic vessels and 
diaphragm (Fig.21B). Severe steatosis is diagnosed when there is marked increase in 
echogenicity with poor penetration of the posterior segment of the right lobe of the liver and 
poor or nonvisualization of hepatic vessels and diaphragm (Fig.21C-D), the so-called bright 
liver on ultrasound (Taylor et al., 1986). Significant findings include hepatomegaly, 
decreased sonographic visualization of portal and hepatic veins and an unusual “fine” liver 
texture (Zwibel, 1995;). 
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Fig. 21. Diffuse steatosis: [A] Mild steatosis: minimal diffuse increase in hepatic echogenicity 
with normal visualization of diaphragm and intrahepatic vessels; [B]Moderate steatosis: 
moderate increase in hepatic echogenicity with slightly impaired visualization of 
intrahepatic vessels and diaphragm; [C-D] Severe steatosis: marked increase in hepatic 
echogenicity with nonvisualization of hepatic vessels and diaphragm. 
3.3.2 Focal steatosis and focal sparing 
Hepatic fatty change is not always uniform but can present as a focal or regional area of 
steatosis in an otherwise normal liver (focal steatosis) or as subtotal fatty change with sparing 
of certain areas (focal sparing) (Baker et al., 1985).  Both processes are common and may cause 
considerable diagnostic confusion, especially in the workout of primary or metastatic 
malignant liver disease (Baker et al., 1985). Aberrant blood supply to those areas has been 
demonstrated to be the underlying etiology for nonuniform change (Arai et al., 1988). In 
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individuals with focal fatty sparing, it is assumed that the spared regions do not have a normal 
portal blood supply and therefore do not receive lipid-rich blood from the gut. Because of their 
underlying vascular aberrance, most of these spared areas have a characteristic location. For 
example, focal fatty sparing of the medial segment of the left liver lobe results from blood 
supply through the gastric veins, whereas aberrant blood supply from the internal thoracic 
artery has been established in some lesions around the falciform ligament (Matsui et al., 1995). 
Other characteristic locations include areas adjacent to the gallbladder fossa, the subcapsular 
region, and the porta hepatis. Islands of normal liver parenchyma may appear as hypoechoic 
masses within a dense, fatty infiltrated liver (Fig.22). 
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Fig. 22. Multifocal steatosis: multifocal increase in echogenicity of the liver parenchyma, 
sparing the segment IV that appears hypoechoic. 
Less clear is why the same areas that can present as focal fatty sparing also have focal fatty 
infiltration. It is hypothesized that decreased delivery of unknown substances from the 
portal vein and relative ischemia from the paucity of portal blood supply are the main 
causative factors. In focal fatty infiltration, regions of increased echogenicity are present 
within a background of normal liver parenchyma and may present as a pseudonodular 
lesion (Fig.23).  On imaging, several observational clues assist with correct identification of 
focal fatty change or focal spared areas:  
1) typical periligamentous and periportal location,  
2) lack of mass effect,  
3) sharply angulated boundaries,  
4) nonspherical shape,  
5) absence of vascular displacement or distortion, and  
6) lobar or segmental distribution. 
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Fig. 23. Pseudonodular steatosis: Echogenic nodule (white arrow) in segment IVB anterior to 
the bifurcation of the portal vein that was confirmed to be a focal nodular steatosis in the 
MRI exam. 
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3.3.3 Cirrhosis 
Cirrhosis is defined by the World Health Organization (WHO) as a diffuse process 
characterized by fibrosis and the conversion of normal liver architecture into structurally 
abnormal nodules. Liver cirrhosis is caused by diffuse fibrosis and regenerating nodules 
that result from liver cell necrosis and degeneration. It is characterized by architectural 
distortion and the development of a spectrum of nodules, ranging from benign regenerating 
nodules to HCC (Brown et al., 1997). In cirrhosis, in its early stages, the liver may appear 
normal. With progression of the disease, nodularity of the liver surface and generalized 
heterogeneity of the hepatic parenchyma can be seen. The porta hepatis and interlobar 
fissure frequently appear widened due to shrinkage of the right lobe and the medial 
segment of the left lobe, with concomitant enlargement of the caudate lobe and the lateral 
segment of the left lobe. The gross morphologic appearance of the cirrhotic liver is 
categorized by the size of the parenchymal nodules: micronodular, macronodular, or mixed.  
Micronodular cirrhosis is characterized by regenerative nodules of relatively uniform small 
size, ranging from 0.1 to 1.0 cm in diameter. This pattern is most commonly seen in chronic 
alcoholic cirrhosis. In macronodular cirrhosis, the parenchymal nodules are larger, coarser, 
and more variable in size, up to 5.0 cm in diameter. The most common cause of 
macronodular cirrhosis is chronic viral hepatitis. 
The sonographic patterns associated with cirrhosis are: 
1. Volume redistribution - In the early stages of cirrhosis, the liver may be enlarged, 
whereas in the advanced stages, the liver is often small, with relative enlargement of the 
caudate and the left lobe, and reduction of the size of the right lobe (Fig.24A). A ratio of 
caudate lobe to right lobe can be derived from a transverse scan of the liver 
immediately below the portal vein bifurcation: this is less than 0.6 in normal subject and 
greater than 0.65 in cirrhosis, with 100% specificity but sensitivities of 84% and 43% in 
two different series (Giorgio et al., 1986; Harbin et al., 1980); 
2. Coarse echotexture - Increased echogenicity and coarse echotexture are frequent 
observations in diffuse liver disease (Fig.24B); 
3. Nodular surface - Irregularity of the liver surface (Fig.24C); 
4. Regenerative and dysplastic nodules - Regenerative nodules tend to be isoechoic or 
hypoechoic with a thin echogenic border. They may give a generalized granularity to 
the liver echotexture in forms of micronodular cirrhosis (Fig.24D). The larger nodules of 
macronodular disease may give an ultrasonically recognizable surface nodularity. 
Dysplastic nodules are considered premalignant.  
Other ultrasound findings in cirrhosis are related to the complications associated with 
hepatocellular failure and portal hypertension: these include ascites, splenomegaly, the 
development of collateral venous channels and other abnormalities of the portal venous 
system.  
3.4 Portal hypertension  
Portal hypertension develops when increased resistance to portal flow and/or increased 
portal blood flow occur.  Normal portal vein pressure is 5 to 10 mm Hg (14cm H2O). Portal 
hypertension is defined by a wedged hepatic vein pressure or direct portal vein pressure of 
more than 5 mm Hg greater than inferior vena cava pressure, splenic vein pressure of 
greater than 15 mm Hg, or portal vein pressure of greater than 30 cm H2O. They result in 
enlargement of the extrahepatic portal vessels, the development of spontaneous 
portosystemic collaterals and slow portal vein flow. Portal hypertension can be classified in  
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Fig. 24. Cirrhosis: [A] Volume redistribution with enlargement of the left and caudate lobes;  
[B] Volume redistribution with coarse echotexture; [C] Longitudinal scans showing 
lobulated contour; [D] Multiple small hypoechoic nodules along the entire liver parenchyma  
(regenerative). 
several ways. We find that the easiest method is to divide it into intrahepatic, extrahepatic, 
and hyperdynamic. Extrahepatic portal hypertension can be subdivided into prehepatic 
(portal vein thrombosis, compression, and stenosis) and posthepatic (hepatic vein or inferior 
vena cava [IVC] thrombosis, compression, or stenosis). The extrahepatic presinusoidal 
portal hypertension should be suspected in any patient who presents with clinical signs of 
portal hypertension - ascites, splenomegaly and varices - and a normal liver biopsy. 
Thrombosis of the portal venous system occurs in children secondary to umbilical vein 
catheterization, omphalitis and neonatal sepsis. In adults, the causes of portal vein 
thrombosis include trauma, sepsis, HCC, pancreatic carcinoma, pancreatitis, portacaval 
shunts, splenomegaly and hypercoagulable states. Hyperdynamic refers to conditions that 
cause arterial portal fistulas or arteriovenous malformations. Extrahepatic portal 
hypertension and hyperdynamic portal hypertension are much less common than the 
intrahepatic category.  Intrahepatic portal hypertension is subdivided into presinusoidal 
and postsinusoidal.  The intrahepatic presinusoidal causes of portal hypertension include 
hepatic fibrosis, sarcoidosis, schistosomiasis, and lymphoma. Postsinusoidal includes 
cirrhosis and venoocclusive disease (Ralls, 1990).  
Cirrhosis is the most common cause of intrahepatic portal hypertension. It causes 
hepatocellular death and parenchymal degeneration and regeneration. This results in 
bridging fibrosis that affects the central venules that drain the sinusoids, as well as the 
sinusoids themselves. The fibrosis causes increased resistance to blood flow. Initially, portal 
vein flow volume is maintained, but at a higher portal pressure.  As the process progresses, 
the resistance to inflow in the liver equalizes with resistance to flow in portosystemic 
collaterals. At this point, portal flow starts to be diverted into the collaterals. As portal 
inflow to the liver decreases, hepatic arterial flow increases, and the arteries become larger 
and more tortuous. Eventually, resistance to arterial inflow reaches a point where arterial 
flow starts to shunt into the portal vein system. This initially produces portal vein flow 
reversal in isolated peripheral portal vein branches. But as more and more peripheral 
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branches reverse, flow in the major branches and eventually the main portal vein reverses 
(Ralls, 1990).  
There are several sonographic findings of portal hypertension. Dilatations of the portal, 
mesenteric and splenic veins are all potential indicators of elevated pressures. Weinreb 
(1982) found 13 mm as the cutoff for upper limit of normal portal vein diameter. In general, 
an unusually large portal vein is a good sign of portal hypertension, but a normal size portal 
vein certainly does not exclude the diagnosis. Lack of caliber variation of the splenic and 
mesenteric vein during respiration is another parameter that has been investigated. This 
approach had a sensitivity of 80% and specificity of 100% in diagnosing portal hypertension 
(Bolondi et al., 1982).   
A variety of Doppler techniques have been used to evaluate patients with suspected portal 
hypertension. Simple measurements of portal vein velocity are one such approach. Zirone et 
al. (1992) found a sensitivity of 88% and a specificity of 96% using a mean portal vein 
velocity cutoff of 15 cm/sec.  Although there is general agreement that portal vein velocities 
usually decrease with portal hypertension, the expected values in control subjects and 
cirrhotic patients vary considerably. Mean portal venous flow velocity is approximately 15 
to 18 cm/sec. Sources of variability include interobserver variability, intermachine 
variability, presence of variable collateral pathways (especially recanalized umbilical veins), 
and variations caused by differences in patient positioning, different phases of respiration, 
states of fasting, exercise status and cardiac output. These variations probably also account 
for the fact that portal velocities tend to decrease as portal pressures increase, but the 
correlation is not statistically significant (Choi et al., 2003; Haag et al., 1999). As portal 
hypertension develops, the flow in the portal vein loses its ondulatory pattern and becomes 
monophasic (Fig.25A-B). As the severity of portal hypertension increases, flow becomes 
biphasic and finally hepatofugal (Fig.25C). The ratio of portal vein cross-sectional area and 
portal velocity has been called the congestion index and has also been used to diagnose 
portal hypertension. Moriyasu et al. (1986) described this index based on the assumption 
that portal vein cross-sectional area will increase and the portal velocity will decrease in the 
setting of portal hypertension, resulting in a quotient that increases dramatically. In this 
study, it was shown that the congestion index was 2.5 times higher in patients with cirrhosis 
and portal hypertension than in control subjects. Normal values were described to be up to 
0.099 cm x sec. The sensitivity of congestion index measurements ranges from 67% to 95% 
(Haag et al., 1999; Moriyasu et al., 1986).   
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Fig. 25. Portal vein flow: [A] Ondulatory normal pattern; [B] Loss of ondulatory flow, 
mantaining the normal hepatopetal flow; [C]Hepatofugal portal vein flow as seen with the 
blue color inside the vein and the graphs below the baseline. 
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Alterations in the hepatic venous waveform can also occur with cirrhosis and portal 
hypertension. In general, the normal pulsatility of hepatic veins is either blunted or 
completely eliminated in patients with cirrhosis (Fig.26A-C). In fact, complete loss of any 
pulsatility has been shown to correlate with a higher Child-Pugh score and decreased 
survival rate (Ohta et al., 1995). The mechanism for this loss of hepatic vein pulsatility is 
unclear, but is likely related to hepatic vein loss of compliance due to hepatic fibrosis or 
stenosis, which can be caused by impression on the hepatic veins by regenerating nodules 
(Lorenz & Winsberg, 1996). 
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Fig. 26. Hepatic vein flow: [A] Normal triphasic flow; [B] Biphasic flow; [C] Monophasic 
(portalized) flow. 
Although measurement of vessel diameters and velocities and calculation of various indices 
have shown promise in certain studies, the most reliable and widely used approach for the 
diagnosis of portal hypertension is the detection of portal systemic collaterals. The left 
gastric vein is the most prevalent portal systemic collateral present in 80% to 90% of patients 
with portal hypertension (Burcharth, 1979; Nunez et al., 1978) and its presence implies an 
increased risk for variceal hemorrhage. Sonographically, the left gastric vein is identified as 
a vessel communicating with the superior aspect of the portal or splenic vein in the region of 
the confluence (Fig. 27). The left lobe of the liver serves as an acoustic window, and when 
the left lobe is small, it may be difficult to visualize this vein. It extends superiorly and to the 
left and typically travels immediately anterior to the bifurcation of the celiac axis. The upper 
limit of normal for the vein diameter is 5 to 6 mm (Lafortune et al., 1984; Wachsberg & 
Simmons, 1994). Unfortunately, dilatation of the left gastric vein above a diameter of 6 mm 
occurs in only 25% of patients with portal hypertension, and it is not necessarily present for 
variceal hemorrhage to occur (Wachsberg & Simmons, 1994). On the other hand, the left 
gastric collateral was the only portal systemic collateral visualized in approximately 75% of 
patients. Other tributaries of the portal system can function as portal systemic collaterals 
and include short gastric veins and branches of the superior and inferior mesenteric veins. 
Identification of hepatofugal flow in any of these vessels is adequate to establish the 
diagnosis of portal hypertension.  
Normally, the umbilical vein is an obliterated fibrous remnant that runs in the ligamentum 
teres. It can be identified in some patients as a hypoechoic band running within the fat of the 
ligamentum teres. It extends from the umbilicus to the most anterior aspect of the umbilical 
segment of the left portal vein. In individuals with no portal hypertension, no flow is 
present in the obliterated umbilical vein, and the fibrous remnant measures less than 3 mm 
(Gibson et al., 1989). In the setting of portal hypertension, the umbilical vein recanalizes and 
develops hepatofugal flow. The recanalized umbilical vein is best seen by scanning the left 
lobe of the liver and identifying the umbilical segment of the left portal vein. The umbilical 
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vein itself travels inferiorly from the umbilical segment of the left portal vein and exits the 
liver where it extends inferiorly along the abdominal wall to the umbilical area (Fig.28A-B). 
From there, it extends further inferiorly to communicate with the inferior epigastric veins. 
Ultimately, it communicates with the iliofemoral system and in this way diverts blood back 
to the systemic circulation.  Although these 2 collaterals are the easiest and most productive 
to analyze, there are other collaterals that can be detected sonographically, albeit with more 
difficulty in some cases. These include short gastric, splenorenal, splenoretroperitoneal, 
superior mesenteric, and inferior mesenteric collaterals.  
 
 
Fig. 27. Left gastric vein: Dilated left gastric vein in a longitudinal scan below the left lobe of 
the liver. 
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Fig. 28. Umbilical vein: [A-B] Recanalized umbilical vein from the falciform ligament to the 
anterior abdominal wall in the umbilical area going down to the hypogastrium. 
Splenorenal collaterals are large spontaneous porto-systemic shunts from the splenic hilum 
or capsule to the left renal vein. It is often difficult to trace these collaterals from the splenic 
vein to the renal vein in continuity. Many times, the detection of multiple collaterals around 
the splenic hilum and an enlarged left renal vein is enough to make the presumptive 
diagnosis of a splenorenal collateral (Fig.29A-B). Splenoretroperitoneal collaterals may 
communicate with perivertebral vessels or gonadal vessels. Superior mesenteric collaterals 
communicate with pancreaticoduodenal veins and retroperitoneal/perivertebral veins. 
Inferior mesenteric collaterals communicate with retroperitoneal veins and hemorrhoidal 
veins. As mentioned earlier, as portal hypertension progresses, flow reversal occurs in 
isolated peripheral portal vein branches (Ralls, 1990; Wachsberg et al., 2002). It is very 
important to realize that most patients with portal hypertension maintain antegrade flow in 
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the main portal vein. In addition to reversed flow, slow flow that alternates between 
antegrade and retrograde is another sign of portal hypertension. 
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Fig. 29. Splenorenal shunt: [A] Dilated left renal vein; [B] Splenorenal shunt: splenic flow in 
blue going to the renal vein in red. 
Portal vein thrombosis has been associated with chronic hepatitis, hepatocellular carcinoma, 
metastatic liver disease, carcinoma of the pancreas, chronic pancreatitis, septicemia, trauma, 
splenectomy, portocaval shunts and hypercoagulable states. Sonographic findings of portal 
vein thrombosis is best visualized in B-mode image and confirmed with color Doppler and 
include echogenic thrombus within the lumen of the vein, portal vein collaterals, expansion 
of the caliber of the vein and cavernous transformations. Cavernous transformation of the 
portal vein refers to numerous wormlike vessels at the porta hepatis, which represent 
periportal collateral circulation. Acute thrombus may appear relatively anechoic and may be 
overlooked unless Doppler interrogation is performed. Malignant thrombosis of the portal 
vein has a high association with HCC and is often expansive. Doppler sonography is useful 
in distinguishing between benign and malignant portal vein thrombi in patients with 
cirrhosis. Both benign and malignant thrombi may demonstrate continuous blood flow. 
Pulsatile arterial flow has been found to be 95% specific for the diagnosis of malignant 
portal vein thrombosis (Fig.18F). The sensitivity was only 62% because many malignant 
thrombi can be hypovascular (Dodd et al., 1995).  
The normal hepatic artery in a fasting patient has a low resistance Doppler flow profile with 
an expected RI ranging from 0.55 to 0.7 (Fig.30A). During systole, the velocity is 
approximately 30-60 cm/sec; while during diastole, it normally slows to approximately 10-
20 cm/sec, which is normally less than the velocity of the portal vein flow. The systolic 
acceleration time is typically less than 0.07 s. Liver disease may manifest in the hepatic 
artery as abnormally elevated (RI >0.7) or decreased (RI <0.55) resistance. High resistance is 
a nonspecific finding that may be seen in the postprandial state, patients of advanced age, 
and diffuse peripheral microvascular compression or disease, as seen in chronic 
hepatocellular disease including cirrhosis, hepatic venous congestion, cold ischemia 
(posttransplantation) and any stage of transplant rejection (Martínez-Noguera et al., 2002).  
The effect of cirrhosis on hepatic arterial microcirculation is complex and variable. Arterial 
resistance has been shown to be decreased, normal, or increased in cirrhotic patients 
(Vassiliades et al., 1993). Some aspects of the disease process, such as inflammatory edema, 
arterial compression by regenerative nodules and arterial compression by stiff noncompliant 
(fibrotic) parenchyma, have been thought to increase resistance (Fig.30B) (Alpern et al., 1987; 
Sacerdoti et al., 1995). Other aspects, such as the “hepatic arterial buffer response” 
(compensatory small artery proliferation and increased numbers of arteriolar beds) and 
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arteriovenous shunting, are thought to decrease resistance (Lautt & Greenway, 1987). The 
overall balance of these factors presumably dictates the observed resistance, and it has been 
shown that hepatic arterial RI is not useful for diagnosing cirrhosis or predicting its severity 
(Lim et al., 2005; Vassiliades et al., 1993). It is important to compare the resistive indexes to 
those from prior examinations of the same patient. 
 
A B
 
Fig. 30. HEPATIC ARTERY: [A] Normal low resistance flow in hepatic artery; [B] High 
resistance flow seen in the hepatic artery of the cirrhotic patient. 
3.5 Liver transplantation 
Liver transplantation has rapidly advanced from an experimental therapy to a mainstream 
treatment option for a wide range of acute and chronic liver diseases. Indications for liver 
transplant have evolved to include previously contraindicated conditions such as 
hepatocellular carcinoma and alcohol-related liver disease. Cirrhosis from chronic hepatitis 
C infection remains the most common indication today. The progressive improvement in 
survival from liver transplantation over the past few years has been due to a combination of 
factors, including better patient selection, improved organ preservation, developments in 
surgical technique, modern immunosuppressive agents and improved postoperative 
management. Overall posttransplant outcomes have steadily improved, with unadjusted 5-
year patient survival rates of 77% among patients transplanted with MELD (Model for End-
Stage Liver Disease) score between 15 and 20, and 72% for those with MELD scores between 
21 and 30 (Merion, 2010). Ultrasound plays an important role in patient selection and 
management, being used in the pre-operative, operative and postoperative periods.  
4. Conclusion 
In conclusion, US imaging is an ideal complementary diagnostic tool to evaluate the liver 
from bench to bedside. Hepatic US can examine the internal architecture of the liver 
parenchyma, biliary system, portal and hepatic vascular supply. US can be regarded as a 
noninvasive method valid for follow-up studies of experimental hepatic diseases in rodents 
for pre-clinical drug or cell based therapy. Also, is the test of choice for assessment and 
follow-up of patients with suspected diffuse or focal hepatic disease, portal hypertension 
and screening for vascular and biliary complications following liver transplantation. 
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